Skip to main content
. 2021 Oct 12;25(1):122–132. doi: 10.1007/s11307-021-01657-2

Fig. 3.

Fig. 3

In vivo fluorescence imaging of orthotopic BxPC-3 pancreas adenocarcinomas with uIgG-800F, uFab2-800F, and uFab-800F during the optimal time period: a NIR images of orthotopic BxPC-3 pancreas adenocarcinomas taken with the Artemis clinical camera 96 h are uIgG-800F (left panel), 48 h are uFab2-800F (middle panel), and 36 h after uFab-800F (left panel) administration. Tumors are identified with a yellow arrow and kidney fluorescence, when present, with a red arrow. Note the lower exposure time needed after uIgG-800F administration reflecting a higher MFI. b TBRs and c tumor MFIs measured using the Pearl do not differ significantly between uIgG-800F, uFab2-800F, and uFab-800F at respectively 96 h, 48 h,and 36 h after injection. a.u., arbitrary units; hrs, hours; MFI, mean fluorescence intensity; ns, not significant; TBR, tumor-to-background ratio; T, time.